Evidence map›Paper›PMID 34206265›Full record

ReviewNutrients2021

Saudi Arabia's Healthy Food Strategy: Progress & Hurdles in the 2030 Road.

Faisal Fahad Bin Sunaid, Ayoub Al-Jawaldeh, Meshal Wasel Almutairi, Rawan Abdulaziz Alobaid, Tagreed Mohammad Alfuraih, Faisal Naser Bensaidan, Atheer Shayea Alragea, Lulu Ali Almutairi, Ali F Duhaim, Talal Ali Alsaloom and 1 more

Abstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Prevalence, risk factors, and interventions for obesity in Saudi Arabia: A systematic review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2022
    Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Faisal Fahad Bin SunaidHealthy Food Department, Saudi Food and Drug Authority, Riyadh 13513-7148, Saudi Arabia.
Ayoub Al-JawaldehRegional Office for the Eastern Mediterranean (EMRO), World Health Organization (WHO), Cairo 11371, Egypt.ORCID 0000-0001-7387-8277
Meshal Wasel AlmutairiHealthy Food Department, Saudi Food and Drug Authority, Riyadh 13513-7148, Saudi Arabia.
Rawan Abdulaziz AlobaidHealthy Food Department, Saudi Food and Drug Authority, Riyadh 13513-7148, Saudi Arabia.
Tagreed Mohammad AlfuraihHealthy Food Department, Saudi Food and Drug Authority, Riyadh 13513-7148, Saudi Arabia.
Faisal Naser BensaidanHealthy Food Department, Saudi Food and Drug Authority, Riyadh 13513-7148, Saudi Arabia.ORCID 0000-0002-0578-8920
Atheer Shayea AlrageaHealthy Food Department, Saudi Food and Drug Authority, Riyadh 13513-7148, Saudi Arabia.
Lulu Ali AlmutairiHealthy Food Department, Saudi Food and Drug Authority, Riyadh 13513-7148, Saudi Arabia.ORCID 0000-0001-9140-8666
Ali F DuhaimHealthy Food Department, Saudi Food and Drug Authority, Riyadh 13513-7148, Saudi Arabia.
Talal Ali AlsaloomHealthy Food Department, Saudi Food and Drug Authority, Riyadh 13513-7148, Saudi Arabia.
Jana JabbourRegional Office for the Eastern Mediterranean (EMRO), World Health Organization (WHO), Cairo 11371, Egypt.ORCID 0000-0002-0576-1031

Funding

World Health Organization 001
6 · The paper itself

Abstract

The Kingdom of Saudi Arabia (KSA) is a leading country worldwide in the prevalence of non-communicable diseases (NCDs), which alone can explain 73% of mortality in the country. In response to the heavy burden of NCDs, the Saudi Food and Drug Authority (SFDA), in collaboration with other government entities, developed a healthy food strategy (HFS) aimed at enhancing healthy lifestyles and reducing the intake of salt, sugar, saturated fatty acids (SSF) and trans fatty acids (TFA). The objectives of the HFS, to facilitate consumers' identification of SSF and reduce the SSF and TFA content in food items, were addressed in collaboration with key stakeholders in the public and private sectors of the food industry. These reforms included voluntary and mandatory schemes to display nutrition information in food and beverage establishments, display allergens on food menus, encourage the adoption of front of pack nutrient labels (FoPNLs) on food products, ban the use of partially hydrogenated oils and establish limits for sodium composition in breads and selected food products. This manuscript contextualizes the HFS and presents the results of monitoring initiatives undertaken by the SFDA to assess compliance with these reforms.

Indexed as

Nutrition PolicyHealthy People ProgramsHumansIntersectoral CollaborationSaudi ArabiaStakeholder ParticipationEastern Mediterranean regionhealth policiesKSAnon-communicable diseasesnutrient labelsnutritionobesitytrans fatty acids

Identifiers

PMID34206265
PMCPMC8308336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.